Novo Nordisk A/S logo

Novo Nordisk A/S - Class B

2
OCSE:NOVO B (Denmark)   Class B
kr 866.20 (+0.41%) Apr 19
46.53
P/B:
36.24
Market Cap:
kr 3.86T ($ 551.94B)
Enterprise V:
kr 3.86T ($ 551.48B)
Volume:
1.94M
Avg Vol (2M):
2.66M
Also Trade In:
Volume:
1.94M
Avg Vol (2M):
2.66M

Business Description

Description
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Financials (Next Earnings Date:2024-05-02)

OCSE:NOVO B's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Novo Nordisk A/S Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil kr) 232,261
EPS (TTM) (kr) 18.615
Beta -0.06
Volatility % 19.32
14-Day RSI 48.14
14-Day ATR (kr) 19.79028
20-Day SMA (kr) 875.635
12-1 Month Momentum % 59.9
52-Week Range (kr) 504.4 - 932
Shares Outstanding (Mil) 4,461.53

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Novo Nordisk A/S Filings

Filing Date Document Date Form
No Filing Data

Novo Nordisk A/S Stock Events

Financials Calendars
Event Date Price(kr)
No Event Data

Novo Nordisk A/S Frequently Asked Questions

What is Novo Nordisk A/S(OCSE:NOVO B)'s stock price today?
The current price of OCSE:NOVO B is kr866.20. The 52 week high of OCSE:NOVO B is kr932.00 and 52 week low is kr504.40.
When is next earnings date of Novo Nordisk A/S(OCSE:NOVO B)?
The next earnings date of Novo Nordisk A/S(OCSE:NOVO B) is 2024-05-02.
Does Novo Nordisk A/S(OCSE:NOVO B) pay dividends? If so, how much?
The  Dividend Yield %  of Novo Nordisk A/S(OCSE:NOVO B) is 1.09% (As of Today), Highest Dividend Payout Ratio of Novo Nordisk A/S(OCSE:NOVO B) was 0.62. The lowest was 0.33. And the median was 0.46. The  Forward Dividend Yield % of Novo Nordisk A/S(OCSE:NOVO B) is 1.48%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release